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ARTICLE
Control of oviductal fluid flow by the G-protein
coupled receptor Adgrd1 is essential for murine
embryo transit
Enrica Bianchi 1, Yi Sun 2,3, Alexandra Almansa-Ordonez1, Michael Woods4, David Goulding5,
Nadia Martinez-Martin2 & Gavin J. Wright 1,6✉
Dysfunction of embryo transport causes ectopic pregnancy which affects approximately 2%
of conceptions in the US and Europe, and is the most common cause of pregnancy-related
death in the first trimester. Embryo transit involves a valve-like tubal-locking phenomenon
that temporarily arrests oocytes at the ampullary-isthmic junction (AIJ) where fertilisation
occurs, but the mechanisms involved are unknown. Here we show that female mice lacking
the orphan adhesion G-protein coupled receptor Adgrd1 are sterile because they do not
relieve the AIJ restraining mechanism, inappropriately retaining embryos within the oviduct.
Adgrd1 is expressed on the oviductal epithelium and the post-ovulatory attenuation of tubal
fluid flow is dysregulated in Adgrd1-deficient mice. Using a large-scale extracellular protein
interaction screen, we identified Plxdc2 as an activating ligand for Adgrd1 displayed on
cumulus cells. Our findings demonstrate that regulating oviductal fluid flow by Adgrd1
controls embryo transit and we present a model where embryo arrest at the AIJ is due to the
balance of abovarial ciliary action and the force of adovarial tubal fluid flow, and in wild-type
oviducts, fluid flow is gradually attenuated through Adgrd1 activation to enable embryo
release. Our findings provide important insights into the molecular mechanisms involved in
embryo transport in mice.
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ctopic pregnancies occur when a fertilised egg implants and
develops outside of the uterus, and in almost all cases, this
occurs in the Fallopian tube resulting in a tubal pregnancy.
The control of embryo movement through the oviduct is there-
fore thought to have an important role in this condition, but
while generic risk factors that include previous IVF treatment and
surgery have been identified, the underlying genetic causes and
mechanisms are poorly characterised1,2.
The oviduct promotes successful fertilisation by storing and
supporting the capacitation of sperm, and providing a conduit for
eggs and early embryos to reach the uterus. The transit of eggs
and embryos through the oviduct is thought to be due to the
combined action of several different factors which include the
beating of cilia in an abovarial direction, periodic contractions of
the surrounding muscle, and regulated secretions from the ovi-
ductal epithelium. One general feature of mammalian oviductal
transport is that ovulated cumulus-oocyte-complexes initially
move rapidly through the infundibulum to the ampulla, and are
then halted for many hours at the ampullary-isthmic junction
(AIJ) before continuing their journey to the uterus3–7. In humans,
the AIJ is the site of fertilisation and the arrest of oocytes is likely
to promote successful reproduction by providing a suitable
environment for the gametes to meet and suppress polyspermy8.
The pausing of tubal passage is a conserved feature of mammalian
oviducts and has been described in several mammals including
mouse3,6, rabbits7, horses9, sheep, pig, guinea pig and cat10. None
of the factors known to be involved in tubal transport provide a
satisfactory explanation for this valve-like behaviour of the ovi-
duct, and especially how it is unlocked to allow the developing
embryos continued passage to the uterus.
Adhesion G-protein coupled receptors are a subfamily of 33
cell surface receptor proteins in humans that contain the arche-
typal seven transmembrane-spanning region that couples extra-
cellular stimuli to intracellular signalling and appropriate cellular
responses through G-protein activation. They are distinguished
by the presence of an N-terminal extracellular region that varies
considerably in length within the subfamily and contains protein
domains whose known functions are to mediate cell and extra-
cellular matrix interactions11. These receptors are expressed on a
wide range of different cell types and gene-deficient mice have
shown that they have a variety of functions ranging from
immunoregulation12,13, development of the nervous system14,
angiogenesis15,16 and male fertility17,18 although there have been
no previous reports of a role in female reproduction. One char-
acteristic feature is the presence of the GAIN (GPCR-Autopro-
teolysis INducing) domain which proteolytically cleaves the
extracellular region at the GPS (GPCR Proteolytic Site) and re-
associates non-covalently to form a heterodimeric receptor.
Activation of these receptors is triggered by the binding of specific
extracellular ligands which relieves an autoinhibitory region
thereby releasing an activatory peptide19,20; however, many
receptors are orphans, having no known ligand.
Here, we report on the action of a gene called Adhesion G-
protein coupled receptor D1 (Adgrd1) which is expressed in the
oviductal epithelium and female mice lacking this gene are sterile
because embryos are retained within the ampulla. Our results
demonstrate an essential role for Adgrd1 in embryo transport and
because oviductal fluid flows are dysregulated in these animals,
provides a plausible explanation for oviductal tubal locking and
how it is regulated.
Results
Adgrd1-deficient female mice are sterile due to defective
embryo transport. To identify genes required for female
fertility with unknown mechanisms of action, we interrogated the
International Mouse Phenotyping Consortium database and
identified a gene encoding an orphan member of the family of
adhesion G-protein coupled receptors, Adgrd121. We confirmed
that female mice containing a targeted Adgrd1 gene-trap allele
(Supplementary Fig. 1) were sterile, irrespective of the male
genotype (Fig. 1a). Female Adgrd1-mutant reproductive tissues
were morphologically normal, and ovulated the same number of
eggs as wild-type littermates (Fig. 1b). Fertilisation of Adgrd1-
deficient oocytes was unaffected both in vivo (Fig. 1c) and in vitro
(Fig. 1d). We did not observe any embryo implantation in
Adgrd1-deficient mothers (Fig. 1e), although Adgrd1−/− uteri
could support embryo development (Fig. 1f, g) since transferred
wild-type embryos developed normally until at least day 12.5
(Fig. 1g—inset). We consistently observed embryos denuded of
cumulus cells that were ectopically located in the ampulla of
mutant mothers (Fig. 1h, i), which had reached the expected
morula stage by 2.5 dpc (Fig. 1j). The remnants of unfertilised
eggs such as empty zonae pellucidae and dead oocytes were also
frequently observed in the ampullae of mutant mothers (Fig. 1h).
Together, these data demonstrate that Adgrd1−/− females are
sterile because embryos are inappropriately retained in the
ampulla, perhaps because they are unable to reverse the tubal lock
that retains eggs at the AIJ.
Adgrd1 is expressed in the oviductal epithelium. To understand
how loss of Adgrd1 regulates embryo passage through the AIJ, we
first asked in which tissues Adgrd1 was expressed. Using the beta-
galactosidase enzyme that is incorporated into the gene trap allele,
we used whole mount X-gal staining to show that the Adgrd1
promoter was highly active in the isthmus in fertile Adgrd1 het-
erozygous mice (Fig. 2a, Supplementary Fig. 2a). The expression in
the isthmus was clearer when the highly coiled oviduct was dis-
sected away from the ovary and uterus and partially extended
(Fig. 2b). To determine the location of the protein, we raised an
antibody to the entire extracellular regions of mouse Adgrd1 and
observed that the protein was expressed throughout the oviductal
epithelial cells in the ampulla in both secretory and ciliated cells
(Fig. 2c); the antibody did not stain oviductal epithelium from
Adgrd1-deficient mice, demonstrating the specificity of the anti-
body (Fig. 2c). At higher magnification, the staining was con-
centrated at the cell surface in both ciliated and non-ciliated
secretory cells (Fig. 2d). Staining sections of the isthmic region of
the oviduct showed Adgrd1 was expressed in the epithelial cells
that line the lumen of the oviduct and not the underlying smooth
muscle (Fig. 2e). We did not observe any major changes in the
level of transcription of Adgrd1 in either the ampullary or isthmic
epithelium between the ovulatory period (0.5 dpc) and after the
embryos had transited through the AIJ (1.5 dpc) (Supplementary
Fig. 2b). These data show that Adgrd1 is expressed on the plasma
membrane of both secretory and ciliated cells in the epithelium of
the oviduct and is not regulated during the oestrous cycle.
The structure and function of oviductal cilia and muscle are
normal. Embryo transport through the oviduct is thought to
involve the concerted effects of oviductal fluid secretions, muscle
contractions, and the action of cilia which beat in an abovarial
direction towards the uterus, although their relative contributions
have not been determined. To provide a mechanistic explanation
for the lack of embryo transport, we first stained oviductal sections
with a ciliary marker which revealed no overt differences in the
ultrastructure of the epithelium nor the number or distribution of
ciliated cells in the Adgrd1-deficient oviduct compared to het-
erozygous controls (Fig. 3a). Using electron microscopy, we
similarly observed no differences in the ultrastructure of the ovi-
ductal cilia (Fig. 3b), nor the typical 9+ 2 arrangement of the
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microtubules (Fig. 3c). To investigate ciliary function more
directly, we placed beads on explants of oviductal ampullary
epithelium and quantified their velocity. Beads placed on both
Adgrd1-mutant explants and controls moved in an abovarial
direction (Supplementary Movie 1), and at similar speeds
(Fig. 3d). These findings were consistent with the transport of the
cumulus complexes from the infundibulum to the ampulla which
was normal in Adgrd1−/− mice, and thought to be largely driven
by ciliary action. We next examined the smooth muscle that lines
the oviduct (the myosalpinx) and observed no overt defects in
muscle organisation or structure in the mutant oviducts (Fig. 3e).
We stained sections of the oviduct with a marker of smooth
muscle and again observed no differences between wild type and
mutant (Fig. 3f, f’). Consistent with this, there were no differences
in the thickness of the myosalpinx in either the ampullary or
isthmic regions of the oviduct (Fig. 3g). By in situ observation of
the oviduct, we did not detect any overt differences in the rhythm
or spatial locations of muscle contractions in Adgrd1-deficient
oviducts. To examine this in more detail, we placed beads into the
lumen of an Adgrd1-mutant oviductal explant to determine the
effects of muscle contractions on their movement and observed
that they were not rigidly held in position, but rather were moved
back and forth in pendulum-like movements due to the contrac-
tions of the surrounding muscle (Supplementary Movie 2). These
observations were consistent with the view that muscle contrac-
tions mix rather than vectorially transport the contents of the
Fig. 1 Adgrd1−/− female mice are infertile due to defective embryo transport. a Adgrd1−/− females are sterile irrespective of the male genotype.
b Adgrd1−/− female mice ovulate comparable numbers of oocytes compared to wild-type controls. Adgrd1−/− oocytes are fertilised at normal
frequencies both in vivo (c) and in vitro (d). e No implantation sites were observed in Adgrd1−/− females. f Adgrd1 mutant uteri support implantation of
transferred wild-type embryos. g Images showing implantation of transferred wild-type embryos in Adgrd1−/− and control uteri at 12.5 dpc; embryos
developed normally (insets). h 2.5 dpc embryos are ectopically located within the ampulla of an Adgrd1−/− oviduct. Arrow identifies morula-stage
embryo, arrowhead identifies a dead oocyte. Scale bar represents 100 µm. i Embryos are ectopically located in the ampulla of Adgrd1−/− mice at 2.5
dpc and 3.5 dpc. j Mutant Adgrd1−/− embryos recovered from the ampulla at 2.5 dpc have reached the morula stage. Scale bar represents 80 µm. Bars
in a, b, c, d, and i represent mean ± SEM. Each data point in a represents a biologically independent mating pair. In b, c, d, e, f and i each data point
represents a single mouse; source data are provided as a Source Data file. h and j are representative examples of at least five independent
experiments.
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tube10. Finally, and similar to experiments in other mammals7,22,
tissue sections of wild type and Adgrd1−/− oviducts throughout
the oestrus cycle failed to reveal a constriction or occlusion at the
AIJ that could explain embryo retention, and this was consistent
with the ease of flushing trapped embryos from the ampulla of
Adgrd1−/− oviducts through the isthmus.
Attenuation of post-ovulatory fluid flow is dysregulated in
Adgrd1-deficient mouse oviducts. Oviductal fluid influences
embryo transport and varies throughout the oestrous cycle,
peaking at ovulation and reducing in volume prior to the next
cycle23–27. Due to the small size and flexuous morphology of the
mouse oviduct, ligation is a practical method of evaluating fluid
production27, and so heterozygous Adgrd1+/− oviductal explants
were ligated at the infundibulum in vitro at 0.5 dpc and 1.5 dpc.
Four hours after ligation of 0.5 dpc oviducts, we observed a striking
distention of the ampulla due to the accumulated fluid (Fig. 4a).
This demonstrated that fluid exits the oviduct at the ovarial end
creating a flow that opposes the movement of embryos - agreeing
with observations in mice27, and larger mammals22,24,28,29.
Consistent with the reduction in fluid production after ovulation,
ligating heterozygous oviducts in the post-ovulatory period (1.5
and 2.5 dpc) resulted in a much reduced accumulation of fluid
(Fig. 4b and c). Adgrd1−/− mutant oviducts ligated at 0.5 dpc
exhibited the same ampullary distention (Fig. 4a); however, by
contrast to heterozygous littermates, did not show the same
reduction at 1.5 and 2.5 dpc demonstrating that the post-ovulatory
attenuation of fluid production in mutant oviducts is dysregulated
(Fig. 4b and c). This was confirmed by performing the ligations
in vivo at 2.5 dpc, which resulted in a more conspicuous distension
of the ampulla due to the accumulated fluid in the mutant com-
pared to heterozygous controls (Fig. 4d and Supplementary
Fig. 3a). Dysregulated fluid production was specifically observed in
the isthmus by ligating oviducts within the isthmus itself (Sup-
plementary Fig. 3b). While these ligation experiments demon-
strated defects in oviductal fluid production, they did not directly
show how oviductal fluid flow was altered in Adgrd1-mutant
oviducts. To address this, we developed a surgery setup similar to
that used by Hino and Yanagimachi27 using a heating jacket that
permitted experimental access to the female reproductive organs to
inject a tracer dye into the oviduct lumen and directly observe fluid
Fig. 2 Adgrd1 is expressed on the plasma membrane of both secretory and ciliated cells in the epithelium of the oviduct. a Adgrd1 promoter is active in
the isthmus of the oviduct as detected by whole mount X-gal staining using the lacZ reporter enzyme. Staining is detected in the homozygous oviducts
(left) but not in the wild-type sibling control (right). b Whole mount X-gal staining of homozygous Adgrd1 oviducts that have been removed from the ovary
and uterus and partially extended to show Adgrd1 promoter activity in the isthmus. c An Adgrd1 polyclonal antibody raised against the entire ectodomain
specifically stains the ampullary epithelium (purple) from wild type (upper panels) but not Adgrd1-deficient mice lower panels); anti-acetylated tubulin
staining was used to mark ciliated cells (green). d Adgrd1 is localised on the apical plasma membrane of ciliated and non-ciliated cells in the oviductal
epithelium. Scale bar represents 10 μm. e, Expression of Adgrd1 in the epithelial cells of the isthmus is (green, upper panel) and nuclei counterstained with
DAPI (blue, lower panel). c and e scale bars represent 50 μm. Representative examples of three independent experiments are shown.
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Fig. 3 Adgrd1-deficient oviducts have morphologically normal cilia and muscle. a The distribution of ciliated cells is similar in the epithelium of control
Adgrd+/− and Adgrd1−/− oviducts. Oviductal sections from adult females in diestrous were stained with an antibody against acetylated tubulin to mark cilia
(green), and nuclei counterstained with DAPI (blue, right panel). b, b’ Ciliated cells analysed by scanning electron microscopy did not differ in mutant
Adgrd1−/− oviducts compared to wild-type controls. c Transmission electron microscopy images of Adgrd1−/− cilia showed the usual 9+ 2 organisation
of microtubules. d Polystyrene beads placed on oviductal epithelium explants moved at equivalent speeds in an abovarial direction in both control and
Adgrd1−/− epithelial tissues. Individual data points are bead velocity quantified with Image J manual tracking for a minimum of 15 s. Bars represent the
mean ± SEM, measurements were performed on 3 Adgrd+/+ and 3 Adgrd1−/− ampullae; an unpaired t-test analysis showed no significant (ns) difference
between the groups. e Image shows 3D projection of oviducts from 17-day-old mice stained with a phalloidin-Texas Red conjugate, demonstrating no overt
difference in muscle structure and organisation between wild type and mutant. f and f’ Representative examples of sections of the isthmus stained with
anti-smooth muscle alpha actin (magenta) and counterstained with DAPI (Cyan). g The thickness of the myosalpinx is similar in controls (hues of grey)
and Adgrd1−/− (hues of red) in the different oviductal regions. Bars represent the mean ± SEM, measurements were performed on 3 Adgrd+/− and 3
Adgrd1−/− oviducts; a minimum of two sections per mouse were analysed. A two-way ANOVA analysis found that the genotype has no effect (ns) while
the difference between the regions of the oviduct is extremely significant (p < 0.0001). a, b, b’, c, e, f, and f’ are representative examples of three
independent experiments.
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movement in situ while maintaining a physiological temperature,
blood circulation and tissue innervation (Supplementary Fig. 4).
We focussed on comparing the fluid flow in Adgrd1-deficient and
control oviducts at 1.5 dpc where the earlier ligation experiments
had demonstrated differences. Consistent with findings from other
groups and our ligation experiments, we observed adovarial flow of
oviductal fluid in both Adgrd1-deficient and control oviducts
(Supplementary Fig. 5 and Supplementary Movie 3). In the control
animals, the dye behaved similarly to that observed by Hino and
Yanagimachi: the dye segregated into several boluses within the
oviduct close to the uterus which then gradually moved towards
the ovary in a saltatory manner that preserved the quantised nature
of the dye distribution (Supplementary Movie 3). By contrast, in
the Adgrd1-deficient oviducts, the tracer dye instantaneously dis-
persed along the entire length of the oviduct so that once filled,
there was relatively little change in the distribution of the dye along
the length of the oviduct over the course of the observation
(Supplementary Fig. 5 and Supplementary Movie 3). To visualise
these different behaviours, we drew kymographs which emphasised
the pulsatile character observed in the fertile controls compared to
the continuous rapid flow in the Adgrd1-deficient oviducts (Fig. 4e
and f). Given these differences in fluid flow, we next asked if there
were differences in secretory cell development in Adgrd1-mutant
oviducts. Using a marker of secretory cells, we observed no dif-
ference in either the relative number or organisation of these cells
within the mutant epithelium (Supplementary Fig. 6). Finally, we
Fig. 4 Adgrd1 regulates post-ovulatory attenuation of oviductal fluid production. a Accumulation of fluid is comparable in ligated control (+/−)
and mutant (−/−) oviductal explants in vitro at 0.5 dpc; ampullary distension is marked with red lines. b No reduction in fluid accumulation in mutant
Adgrd1−/− oviducts at 1.5 dpc by contrast to heterozygous control. c Oviductal ligation at 2.5 dpc in vitro: more fluid has accumulated in the ampulla of the
mutant compared to control. d The ampulla of mutant (−/−) oviducts exhibited a more pronounced distension compared to heterozygous control (+/−)
after in vivo ligated at 2.5 dpc and collected four hours later; the ampullary region is highlighted by dotted red lines. Images in a, b, c and d are
representative of at least three independent experiments and the scale bar represents 500 μm. e Schematic showing the region of the oviduct used for
producing the kymographs. f Kymographs showing the behaviour of a tracer dye injected into the oviduct of Adgrd1-mutants compared to wild type
littermate control. Adgrd1-mutant oviducts are rapidly filled with the dye which does not change over the time of observation whereas control oviducts
segregate the dye into boluses which are gradually moved towards the ampulla. g Glass beads (~100 μm diameter) were inappropriately retained in the
ampulla of Adgrd1−/− oviducts. Image taken 24 h after bead transplantation. h Magnification of the boxed area in g, showing glass beads and retained
embryo (arrowhead). Scale bars represent 80 μm, images are representative of four independent experiments. i Distribution of 10 to 12 transplanted glass
beads in Adgrd1−/− (n= 4) and control (n= 3) oviducts at 1.5 dpc.
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reasoned that if embryo retention was due to dysregulated ovi-
ductal fluid production, the transport of particles other than
embryos would be affected. Consistent with this, we found that
appropriately-sized glass beads were similarly retained within the
ampulla of Adgrd1−/− but not control oviducts (Fig. 4g, h and i).
Together, these results show that the postovulatory cessation of
oviductal fluid flow is misregulated in the oviduct of Adgrd1-
deficient mice which could prevent embryo passage of the AIJ and
cause infertility.
The ADGRD1 ligand PLXDC2 is expressed on cumulus cells.
Adgrd1 encodes a cell surface receptor belonging to the adhesion
G-protein coupled receptor family, a subset of over 30 proteins
that typically contain a large N-terminal ectodomain, most of
which have no identified ligand30. Adgrd1 contains a pentraxin
domain in its extracellular region and is known to initiate
intracellular signalling by stimulatory G proteins leading to
increases in cAMP levels by activating adenylate cyclase19. One
mechanism to trigger G-protein signalling used by this family of
receptors is through the ligand-dependent relief of an auto-
inhibitory ectodomain30–32. To identify a ligand for ADGRD1, we
first expressed the entire ectodomain as a multimeric binding
probe to increase binding avidity and thereby circumvent the
often weak binding affinities of extracellular receptor-ligand
interactions33. The highly avid ADGRD1 binding probe was then
systematically tested in an unbiased manner for binding to a
panel of 1132 unique human receptor ectodomains34, and the
Plexin Domain-Containing Protein 2 (PLXDC2) was identified as
a candidate ligand (Supplementary Fig. 7a). To investigate this
further, we used an assay designed to detect direct extracellular
receptor-ligand interactions called AVEXIS35 and demonstrated
that ADGRD1 and PLXDC2 interacted in both bait-prey orien-
tations (Fig. 5a). To further validate the interaction, we expressed
the entire ectodomains of the mouse orthologues of both Adgrd1
and Plxdc2, and showed that they could directly interact (Fig. 5a).
Cells transfected with a plasmid encoding Plxdc2 gained the
ability to bind the highly avid Adgrd1 binding probe, and this
binding was specifically blocked by preincubating the transfected
cells with an anti-Plxdc2 antibody (Fig. 5b). We next mapped the
interaction interface to the pentraxin domain of Adgrd1 and the
PSI domain of Plxdc2 by creating a series of truncated ectodo-
mains that encompassed known domains of both proteins and
using the AVEXIS assay to quantify binding (Fig. 5c, d and
Supplementary Fig. 7b). To understand how the Adgrd1 receptor
could be activated in the oviduct, we characterised the tissue
expression patterns of Plxdc2. Within the female reproductive
system, Plxdc2 was most highly transcribed in the ovary and
cumulus-oocyte complexes (COCs) compared to the uterus and
oviduct and other tissues such as brain, liver and spleen (Sup-
plementary Fig. 7c). We confirmed the expression of Plxdc2
protein in the ovary and COCs by Western blotting (Fig. 5e), and
showed using immunocytochemistry that Plxdc2 was highly
expressed on the surface of cumulus cells (Fig. 5f). We demon-
strated that Plxdc2 is an activating ligand for Adgrd1 using an
established GPCR activation assay which measures the increase in
cellular cAMP levels36. Adgrd1-transfected HEK293 cells showed
an expected increase in cAMP levels37 which was augmented by
Plxdc2 (Fig. 5g). Together, these results identify Plxdc2, which is
expressed on cumulus cells as an activating ligand for Adgrd1.
Discussion
Ectopic pregnancy is a relatively common complication which
affects up to 2% of all pregnancies in the United States and Europe
and is a major risk factor for maternal health. Despite being so
prevalent, we know remarkably little about the underlying causes
which has prevented progress on developing treatments and
diagnostics. The currently known risk factors are generic (previous
IVF treatment, smoking, damage to the Fallopian tube due to
surgery or infection) and therefore lack any insight into the
underlying mechanisms involved. The few genetic studies in
humans have reported dysregulated expression of genes at the site
of ectopic implantation including HOXA1038, leukaemia inhibi-
tory factor39, and MUC140, but these observational studies do not
distinguish between cause and consequence. Female mice lacking
functional cannabinoid receptor1 (Cnr1) have reported defects in
embryo transport, although the phenotype differs from Adgrd1
mutant mice because they are only subfertile, with 65% of mothers
still showing embryo implantation within the uterus. Moreover,
the defect results in a delay of embryo transport rather than
complete block, because embryos are recovered from the isthmus
and are not retained within the ampulla41. Our finding that female
mice lacking functional Adgrd1 are sterile due to embryo reten-
tion in the ampulla provides strong evidence that embryo trans-
port is genetically controlled.
Beyond unequivocally demonstrating a genetic basis for
embryo transport, our results also provide a mechanism to
explain the valve-like behaviour of the mammalian oviduct. We
present a model (Fig. 6) where ovulated COCs are propelled
towards the uterus by ciliary action but are halted at the AIJ due
to the opposing force of oviductal fluid flowing towards the ovary
caused by the narrowing of the oviduct at the isthmus. Adgrd1 is
locally activated in the oviductal epithelium by Plxdc2 displayed
on the surface of cumulus cells that are progressively released as
the jelly-like hyaluronic acid matrix surrounding the cumulus
mass gradually disintegrates. The triggering of Adgrd1 decreases
oviductal fluid production and consequently the flow that
opposes the constitutive abovarial ciliary action to permit con-
tinued passage of embryos through the isthmus. This suggests
that cumulus cells not only support oocyte development, but also
communicate with the oviduct to regulate tubal transit. While the
flow of the oviductal fluid towards the ovary which opposes the
movement of embryos appears counterintuitive, this behaviour
has been reported in several mammals and likely assists the ascent
of sperm from the storage regions in the isthmus towards the site
of fertilisation. It was first reported in larger animals such as
cattle22, sheep24 and rabbits28 where the surgical implantation of
cannulas can be achieved more easily, but more recently observed
directly using video microscopy in mice27. In mice, the fluid
empties out into the peritoneal cavity through a hole in the
ovarian bursa and the rate of flow is surprisingly high, estimated
at 2.2 microlitres per hour in the periovulatory period but
decreasing by 1.5 dpc27.
One area for future investigation is to understand how Plxdc2
mediated activation of Adgrd1 and the consequent increase in
cAMP within the oviductal epithelial cells leads to changes in
fluid flow to regulate embryo passage. Consistent with our find-
ings, prior research using perfused and cannulated oviducts has
shown that increasing cAMP concentrations by adding a cell
permeable analogue of cAMP (dibutyryl cAMP) or agents that
increase cAMP levels such as forskolin, theophylline and cholera
toxin all resulted in a decrease or abolition of oviductal secretion
in humans42 and rabbits23,43. These results are in keeping with a
regulatory role for fluid secretion and the fact that we observed no
changes in the relative number and organization of the secretory
cells in the oviducts of Adgrd1-deficient mice. The addition of
inhibitors of ion channels that may be regulated by cAMP levels
to oviducts such as bumetanide and 5-nitro-2- (3-phenylpropyl-
amino) benzoic acid did not provide any further insight, but these
experiments were compromised because they were performed on
explanted oviducts which are separated from the circulation and
innervation. One possibility is that fluid flow could be regulated
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by changes in the tone of the myosalpinx to control the rigidity of
the oviduct. In our characterisation of the Adgrd1-deficient ovi-
ducts, however, we observed no morphological or developmental
defects within the oviductal smooth muscle, and when observed
in situ, the contractions appeared completely normal in terms of
their frequency, strength, and localisation. It has been convin-
cingly shown by others that ablating oviductal muscle contrac-
tions using nicardipine had no effect on the rate of oviductal fluid
flow27 suggesting no direct role of muscle in regulating oviductal
fluid flow. Similarly, previous attempts to explain the tubal-
locking phenomenon led to careful histological examination of
the muscles at the AIJ, and did not reveal a sphincter-like
organization7,22, and complete resection of the AIJ did not affect
the fertility of rabbits44. If the myosalpinx does play a regulatory
role in fluid flow, then these changes are likely to be subtle and
gradual, and will therefore require advanced longer term in vivo
imaging to investigate.
The roles of PLXDC2 and ADGRD1 in humans are poorly
characterised and our findings warrant further investigations,
particularly for any role they may have in reproduction and
ectopic pregnancy. Both genes are additionally expressed outside
of the female reproductive system suggesting other functions, and
systematic mouse knockout phenotyping have reported bone
mineralisation phenotypes as well as female sterility for Adgrd1
(see the significant phenotypes reported by the International
Mouse Consortium https://www.mousephenotype.org/data/
genes/MGI:3041203). Mice containing a transgene targeting the
majority of the signal peptide of Plxdc2 resulted in a ten-fold
decrease in Plxdc2 transcript levels in the cerebella45 but no
abnormal phenotypes were reported. One suggested possibility is
Fig. 5 Plxdc2 is an activating ligand for Adgrd1 and expressed on cumulus cells. a Direct interactions between human and mouse ADGRD1 and PLXDC2
ectodomains in both bait-prey orientations using the AVEXIS assay (n= 3 independent replicates). b Adgrd1 ectodomain probe bound Plxdc2-transfected
cells (left panel) and was blocked by preincubation with Plxdc2 antiserum (right). Scale bar represents 10 μm. c Schematic of ADGRD1 and PLXDC2
domain organisation. d Domain truncations demonstrate that the pentraxin (PTX) domain of Adgrd1 and PSI domain of Plxdc2 are sufficient for binding
(n= 4 independent replicates). eWestern blotting and immunofluorescence f demonstrates that Plxdc2 is expressed on the plasma membrane of cumulus
cells. HEK293T cells were used as negative control in e, anti-Juno shows the localisation of the oocyte in f. g The overexpression of Adgrd1 induces a
significant increase of intracellular cAMP compared to non-transfected cells (mock) and to cells transfected with a plasmid encoding GFP (vector). The
Plxdc2 ectodomain induces a significant increase of cAMP levels in Adgrd1-expressing cells only. (n= 2 independent experiments). Bars in a, d, and g
represent mean ± SEM.
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that a gene encoding a related protein, Plxdc1, might compensate
for the role of Plxdc2. Genome-wide association studies have
implicated polymorphisms linked to ADGRD1 with variations in
adult height46,47 and heart beating frequency in electro-
cardiograms48. Subsequent studies focussed on ADGRD1, repor-
ted no clinical phenotypes in adults that are heterozygous for
predicted loss of function alleles consistent with our findings in
mice49. Importantly, tubal ectopic pregnancies are restricted to
primates and are not observed in other animals1. In mice,
embryos recovered from the ampulla of Adgrd1-deficient mice
had not developed beyond the blastocyst stage in agreement with
the reported ability of the ampulla to sustain the development
in vitro to that stage50, and suggesting that the ampulla cannot
support embryo implantation and further development.
Our demonstration that Adgrd1 is essential for embryo
transport provides strong evidence that embryo transport is
genetically controlled, and provides a plausible mechanism to
explain how the tubal locking phenomenon described many years
ago in the mammalian oviduct is regulated. Ectopic pregnancy is
a common and potentially deadly condition for which we have
very little mechanistic understanding, and so our findings here
not only provide potential starting points to develop diagnostics
and treatments but also an animal model to study this condition
further.
Methods
Generation, breeding and fertility phenotyping of Adgrd1-deficient mice. All
animal experiments were performed under UK Home Office governmental reg-
ulations and European directive 2010/63/EU. Research was approved by the Sanger
Institute Animal Welfare and Ethical Review Board. Adgrd1−/− mice were
obtained from the Knockout Mouse Project resource (IKMC Project: 22527) and
contain a lacZ-tagged allele targeted to the Adgrd1 genomic locus located on
chromosome 5, Adgrd1tm1b(EUCOMM/Wtsi). Mice were generated by injecting blas-
tocysts with the targeted mouse embryonic stem cells which were transferred to
pseudopregnant females to generate chimeras. Germline transmission of the tar-
geted allele was confirmed by PCR after mating of chimeric males with C57BL/
6NTac females. To obtain the reporter-tagged deletion allele, females heterozygous
for the ‘knockout-first’ allele Adgrd1tm1a(EUCOMM/Wtsi) were crossed to hemizygous
males ubiquitously expressing the Cre enzyme51. Mice with the recombined allele
were identified using PCR and diagnostic primers using genomic DNA extracted
from ear biopsies (4403319 DNA Extract All Reagents Kit, Life Technologies) as
the template for short range PCR using Platinum® Taq DNA Polymerase
(10966034 Invitrogen). The mouse colony was maintained by crossing hetero-
zygous males and females. Male and female fertility was quantified by pairing
homozygous and heterozygous Adgrd1 transgenic adult mice with homozygous
and heterozygous animals of proven fertility and the number of resulting pups was
monitored continuously for three months. The number of ovulated oocytes was
counted after induction of ovulation with 5 IU of pregnant mare serum
gonadotropin (PMSG) followed by 5 IU of human chorionic gonadotropin (hCG)
48 h later. In vivo fertilisation was assessed by scoring the number of zygotes and
the number of non-fertilised oocytes present in the ampulla at 0.5 dpc. Eggs and
embryos were fixed in 4% formalin (28906 Thermo Scientific Pierce) and stained
with DAPI (62248 Thermo Fisher). In vitro fertilisation was performed essentially
as described52. Briefly, sperm were collected from the cauda epididymis of adult
male mice, capacitated for 1 h in HTF medium at 37 °C and added to cumulus-
enclosed oocytes that had been collected 13 h after hCG treatment. Groups of 20 to
30 eggs were inseminated in 100 μL drops of HTF medium containing 1 × 105
sperm; four hours later, eggs were washed and cultured in KSOM (MR-121D
EmbryoMax, Millipore) for the following four days. Formation of pronuclei was
scored and embryo development recorded daily. Mutant and age-matched control
females were mated with proven males and the day of vaginal plug formation was
counted as 0.5 dpc. The female reproductive tracts were visually inspected for the
presence of implantation sites at 5.5 dpc, 6.5 dpc and 8.5 dpc. The embryo position
in the oviducts was determined using the Zeiss Axioplan 2 microscope and
embryos were counted after flushing the oviducts with M2 medium (Sigma).
Non-surgical embryo transfer (NSET) was performed as described53. Wild-type
2-cell embryos were cultured in KSOM for 48 h and blastocysts were transferred to
pseudopregnant Adgrd1+/+ and Adgrd1−/− recipient females at 2.5 dpc using the
NSET device (Paratechs, catalogue #60010). 14 and 16 blastocysts were transferred
to two wild-type females, and 14, 17, 29 and 30 blastocysts were transferred to four
Adgrd1-deficient females. The number of implanted embryos was counted ten days
after the transfer.
Time-lapse video microscopy. Oviducts were carefully dissected from 8-week-old
females at the required stage of the oestrus cycle. Entire oviducts were separated
from the ovary by opening the ovarian bursa, and scission of the ovarian ligament;
isolation from the rest of the reproductive tract was achieved by trimming the
broad ligament whilst maintaining the utero-tubal junction. When cutting the
mesosalpinx, care was taken to avoid pulling and damaging the tubes. Spontaneous
rhythmic contractions of oviducts were documented by video recording immedi-
ately after dissection using a Zeiss Axioplan 2 microscope equipped with a
Hamamatsu 1394 ORCA-ERA digital camera and the Velocity imaging software.
Fifty seconds of real time were acquired at a frame frequency of 1 Hz. To record
ciliary beating, the ampullary region of the oviducts were opened longitudinally,
placed in PBS on a microscope glass and microparticles (Sigma 74964) were gently
added to the tissue. Movies were acquired at 8.5 frames per second.
Micro beads (Micro particles based on polystyrene, 15μm of diameter; no.
74964 Merck Life Science) were applied to longitudinally opened ampullae in
DPBS with Ca2+ and Mg2+, and live videos were recorded with a stereomicroscope
(Leica M205FA) equipped with the Leica DFC7000T camera. The velocity of bead
transport was quantified with Image J manual tracking for a minimum of 15 s
per bead.
Visualisation and analysis of the oviductal fluid flow. The design of the plastic
jacket was drawn with AutoCAD Inventor and printed with Ultimaker 2+ Connect
3Dprinter using a PolySmooth printing filament. After printing the surface was
smoothed with Isopropanol and the lid was sealed, finally the surface was treated
with the Polymaker Polysher from 3DJake UK to prevent leakage. In preparation
for surgery the jacket was connected to a motor water pump immersed in warm
water. For the visualisation of oviductal fluid flow female mice were mated, selected
at the required time, and prepared for surgery as described above. The ovary and
Fig. 6 Model describing Adgrd1-mediated control of fluid flow underlies the valve-like behaviour of the mammalian oviduct. Cumulus-oocyte-
complexes are ovulated into the infundibulum and rapidly transported to the AIJ by the action of the cilia lining the oviductal epithelium beating towards
the uterus. At the AIJ, the COCs are halted due to the balance of abovarial ciliary action and the force of adovarial oviductal fluid flow (purple arrows). In
wild-type oviducts, the gradual release of cumulus cells as the hyaluronic acid matrix which surrounds them slowly disintegrates releases the Plxdc2 ligand
and triggers a reduction of oviductal fluid production by activating Adgrd1 on the oviductal epithelium to licence embryo release. COC= cumulus-oocyte-
complex; AIJ= ampullary-isthmic junction; UTJ= uterotubal junction.
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the oviduct were exposed on the surface of the surgical incision and manipulated
with care to avoid damaging the tissues. A topical tissue adhesive (Gluture, Zoetis)
was used to hold the fat pad and the ovary onto the skin on one side of the incision.
The jacket containing circulating warm water was sealed to the mouse skin and
pre-warmed DPBS with Ca2+ and Mg2+ (Hyclone SH30264) was added to
maintain the tissues at ~37 °C. A 40 μm bevelled glass pipette (BioMedical
Instruments VESbv-40-0-0-55) was used to inject a tracer dye (India Ink) in the
lower isthmus. The dye was dialysed overnight in DPBS and diluted twofold in the
same buffer before injections. Videos were recorded with the Leica MC170HD
camera at 24fps and retrospectively analysed. Kymographs were generated with the
dedicated Image J plug-in by selecting a region encompassing the oviducts for a
total of 12.5 seconds.
Wholemount LacZ staining, immunofluorescence and immunohistochemistry.
To determine the expression of the lacZ reporter gene in the targeted allele at the
Adgrd1 locus, dissected tissues were fixed in 10% Neutral Buffered Formalin (NBF,
Cellpath) overnight, washed with PBS, stained with a LacZ staining solution (2 mM
MgCl2, 0.02% IGEPAL CA-630, 5 mM potassium ferrocyanide, 5 mM potassium
ferricyanide, 0.01% deoxycholic acid, 0.1% X-Gal (5-bromo-4-chloro-3-indolyl
β-D-galactopyranoside) in dimethylformamide) at 4 °C, post-fixed in 4% formalin
and stored in 70% glycerol.
Polyclonal antiserum was raised by immunising rabbits with the entire
ectodomains of mouse ADGRD1 or mouse PLXDC2 expressed as soluble
recombinant 6-his-tagged proteins in HEK293-6E cells and purified using Ni2+-
NTA chromatography, essentially as described54. Immunisations were carried out
by Cambridge Research Biochemicals in accordance with UK Home Office
regulations and the Sanger Institute animal welfare ethical review board.
To prepare wholemount tissues for immunofluorescence, they were fixed in 4%
formalin for 30 min at room temperature, incubated with the primary antibody for
1 h, and washed extensively with PBS and finally stained with the secondary
antibody conjugated with the appropriate fluorochrome (Alexa Fluor 488 goat anti-
mouse supplied by Thermo Fisher, and Alexa Fluor 647 goat anti-rabbit supplied
by Jackson Immunoresearch). Where tissues were sectioned, tissue was fixed in 4%
formalin for 60 min, rinsed extensively in PBS and soaked in a sucrose solution
overnight before embedding in OCT and 8 micron sections cut with a Leica
CM1950 cryostat. Sections were treated with 1% SDS in PBS for 5 min, blocked
before adding primary antibody overnight at 4 °C. Sections were washed and
incubated with a goat anti-rabbit – Alexa488 secondary antibody for 1 h at room
temperature. Sections were then washed and mounted in slowFade Gold mounting
solution with DAPI (Thermo).
Binding of recombinant proteins to cells was quantified by incubating
transfected cells with highly avid ectodomains expressed as FLAG-tagged
pentameric preys in cell culture medium at 37 °C before fixation in a phosphate-
buffered 4% formalin solution. Staining of muscle was performed by first
permeabilizing fixed oviducts with 0.2% Triton X-100 and incubating with Texas-
Red-phalloidin conjugate for 30 minutes. Optical sections of whole oviductal tissue
were acquired with a Leica SP5 laser confocal microscope (z-step size = 2.52μm).
The 3D projection of the whole z-stack was generated with the LAS AF software.
The antibodies and probes and the dilutions used in this study were: polyclonal
rabbit-anti-mouse Adgrd1 (this study) 1:100; polyclonal rabbit-anti-mouse Plxdc2
(this study) 1:100; rat monoclonal anti-mouse Juno (clone TH6, Biolegend) 1:200;
mouse monoclonal anti-acetylated Tubulin (clone 6-11B-1, Sigma Aldrich); anti-
Pax8 rabbit polyclonal antibody (10336-1-AP, Proteintech) 1:400; mouse
monoclonal anti-alpha smooth muscle Actin (clone 1A4, A2547, Sigma) 1:400;
mouse monoclonal anti-Flag-Cy3 conjugate (clone M2, Sigma Aldrich) 1:500;
Texas-red conjugated phalloidin (Thermo Fisher, T7471); Alexa Fluor 633 goat
anti-mouse IgG (Thermo Fisher A-21052)1:500; Alexa Fluor 488 goat anti-mouse
IgG (405319 Biolegend) 1:500; Alexa Fluor 488 goat anti-rabbit IgG (111-545-003
Jackson Immunoresearch) 1:500; pentameric FLAG-tagged PLXDC2 (this
study) 1:10.
Transmission and scanning electron microscopy. Mouse oviducts were fixed at
room temperature in a 2% formalin/2.5% glutaraldehyde mixture buffered in 0.1 M
sodium cacodylate at pH 7.4 for one hour, rinsed and fixed in 1% osmium tetroxide
for another hour followed by 1% tannic acid and 1% sodium sulphite for 30
minutes respectively. Samples were then dehydrated in an ethanol series, staining
en bloc with uranyl acetate at the 30% stage before embedding (Epoxy embedding
medium kit – Sigma). 50 nm ultrathin sections were cut on a Leica UC6 ultra-
microtome and imaged on an FEI 120 kV Spirit Biotwin TEM with a F4.15 Tietz
camera.
For scanning electron microscopy, mouse oviducts were fixed as for TEM
(replacing tannic acid with osmium-thiocarbohydrazide), dehydrated in an ethanol
series, critical point dried in a Leica CPD300, mounted and sputter-coated with
2 nm of platinum using a Leica ACE600 evaporator. Samples were imaged on a
Hitachi SU8030 SEM.
Oviduct ligation, surgical procedures and transfer of beads. Oviducts from
mice at the required stage in the oestrus cycle were dissected under a Nikon
SMZ800 stereo microscope. Once the ovary was separated from the oviduct and
removed, a surgeon’s knot was tied around the oviduct with polypropylene suture
(Ethicon Prolene 10-0, W2794). The ligated oviducts were maintained in culture at
37 °C in 500 µL of pre-warmed KSOM media, fixed in NBF overnight, and imaged
with a Leica M205FA stereomicroscope.
Glass beads with a diameter of ~100 μm (Sigma G4649) for transfer into
oviducts were sterilised by autoclaving and washed in M2 medium. Female
recipient mice whose mating had been timed were prepared for surgery using
gaseous anaesthesia under aseptic conditions, shaved, and given analgesia. Using a
stereomicroscope (Leica MZ7.5), a small longitudinal skin incision was made at the
midline, level with the last rib. The ovary was located through the muscle wall and
micro scissors were used to make a small incision, followed by blunt dissection
and exteriorisation of the ovary and oviduct by holding the associated fat pad,
anchored using a serrefine clamp. After removing the bursa covering the ovary and
oviduct, glass beads were taken up using a mouth pipette into a 230 mm Pasteur
glass pipette with the aid of a stereomicroscope (Leica MZ9.5) and transferred into
the oviducts of recipient mice at 0.5 dpc. The location of the beads in the ampulla
and isthmus were counted at 1.5 dpc. In vivo ligation of oviducts was performed
using the same surgical procedure with polypropylene suture which was slid under
the oviduct ~1 mm from the infundibulum and fine forceps used to tie a surgeon’s
knot. When assessing fluid accumulation in the isthmus, additional ligatures were
tied at the ampullary-isthmic junction and the isthmus. The ovary and oviduct
were carefully replaced within the body cavity using blunt forceps, and the skin
incision closed using a single wound clip.
Preparation of the protein library for large-scale receptor screening. A library
of single-transmembrane-spanning (STM) human proteins was compiled using
computational prediction algorithms and experimental evidence, as described25.
The ectodomain of each protein was synthesised and cloned into the pRK5 vector
(Genentech) in frame with a C-terminal Fc (hIgG1) tag. The resulting library
consists of 1364 human proteins, including 1132 unique receptors and a number of
replicate constructs as assay controls. Expression of the human STM protein library
was performed as described34. In brief, conditioned media enriched in individual
receptors was prepared in Expi293F cells (Thermo Fisher), transiently transfected
with receptors expressed as ectodomains fused to a human Fc (IgG1). Expi293F
cells were cultured in Expi293 Expression Media (Cell Technologies) in flasks at
37 °C and 150 r.p.m. agitation in a humidified incubator. Human cells were chosen
for expression of the collection of STM receptors to maximise protein quality and
incorporation of relevant post-translational modifications. One mL cell transfec-
tions were performed using an automated system consisting of a TECAN liquid
handling system and a MultiDrop reagent dispenser. Transfections were processed
in batches of 96 clones using a Biomek FX liquid handling robot and conditioned
media was harvested 7 days post-transfection. Subsequently, the receptor Fc-tagged
ectodomains present in the conditioned media were captured on protein A-coated
384-plates (Thermo Scientific), and stored at 4 °C until use. For the binding screen,
the ectodomain of ADGRD1, truncated at S600, was expressed in HEK293-6E cells
as a pentameric probe fused to a beta-lactamase enzyme55. A Thr to Gly mutation
at position 574 in the GPCR proteolytic site (GPS) of human ADGRD1 was
introduced to prevent the autoproteolysis56.
Identification of binding extracellular ligands for ADGRD1. The Cell Surface
Receptor Interaction screening was based on the AVEXIS method35, which was
further implemented for automated high throughput screening in 384 well plate
format, as recently described34. In brief, screens were performed using an inte-
grated robotic system consisting of automated liquid handling devices for high
throughput analysis of receptor-ligand interactions. On the day of the assays, the
protein A plates coated with the receptor library were washed with PBS containing
Ca2+ and Mg2+, followed by incubation with the beta-lactamase-tagged penta-
meric ADGRD1 probe for 1 h at room temperature. Plates were then washed to
remove free protein prior to addition of nitrocefin (Calbiochem) for 1 h at room
temperature. Hydrolysis of the beta-lactamase substrate nitrocefin was quantified
by measuring absorbance at 485 nm using an integrated TECAN plate reader. The
raw enzymatic absorbance values were analysed to calculate Z-scores across all
proteins in the library. Comparisons to previous screens of this type identified
immobilised ligands which repeatedly gave positive binding signals irrespective of
the binding probes used, and included known lectins (e.g., SIGLEC family mem-
bers and MRC1) which are likely to directly interact with common glycans pre-
sented on the binding probe.
Recombinant protein production and protein interaction screening. The
extracellular domains of ADGRD1 and PLXDC2 were expressed as soluble secreted
proteins by transient transfection in HEK293-6E cells55. NCBI reference sequences
for the expressed proteins were: mouse Adgrd1: NP_001074811; human ADGRD1:
NP_001317426; mouse Plxdc2: NP_080438; human PLXDC2: NP_116201. The
region encoding the entire predicted ectodomain was chemically synthesised by
gene synthesis (GeneArt, Life Technologies) flanked by unique NotI, AscI
restriction sites to facilitate cloning into mammalian expression plasmids to pro-
duce enzymatically biotinylatable monomeric ‘baits’ or pentameric FLAG-tagged
‘preys’; both bait and preys contained a rat Cd4d3+ 4 epitope tag as described.
Biotinylated proteins were produced by co-transfecting a plasmid encoding a
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secreted version of the BirA enzyme55. To produce recombinant proteins corre-
sponding to specific regions of both ADGRD1 and PLXDC2 ectodomains, primers
were designed that would amplify the appropriate region from the plasmid
encoding the entire ectodomain by PCR and the products cloned into both bait and
prey expression plasmids using unique NotI and AscI sites54. Bait proteins were
normalised by ELISA using a monoclonal antibody (Ox68) recognising the rat
Cd4d3+ 4 tag. Prey proteins were normalised to their β-lactamase activity to levels
suitable for the AVEXIS assay as described57. Biotinylated baits that had been
either purified or dialysed against PBS to remove excess free D-biotin were
immobilised in streptavidin-coated 96-well microtitre plates (NUNC). Preys were
incubated for one hour, washed three times in PBS/0.1% Tween-20 and once in
PBS. Finally, 60 µl of 125 µg/ml nitrocefin was added and the absorbance measured
at 485 nm on a Pherastar plus (BMG laboratories). A biotinylated protein con-
sisting of just the rat Cd4d3+ 4 tag alone was used as a negative control bait and a
biotinylated Ox68 monoclonal antibody (anti-prey) diluted 1:2,000 was used as an
internal control. The rat Cd200-Cd200R interaction was used as a positive control.
Western blot. To perform Western blotting, proteins from mouse ovary, ovulated
COCs, and HEK293-T were extracted with RIPA buffer and quantified with
Bradford assay (Thermo) following manufacturer’s instructions. Briefly, normalised
protein amounts were resolved under reducing conditions by SDS–PAGE and
blotted to Hybond-P PVDF membrane (GE Healthcare) for 1 h at 30 V. After
blocking for 1 h with 2% BSA, the membrane was incubated for 1 h with Plxdc2
antiserum diluted 1:100 or with anti beta-Actin (Abcam, ab8227) diluted 1:1000 in
PBST(PBS/0.1% Tween-20) added with 2% BSA, washed three times and incubated
with a horseradish peroxidase (HRP)-conjugated anti-rabbit antibody (Thermo-
Fisher Scientific Cat. No. G21234) diluted 1:5,000. Proteins were detected using
SuperSignalWest Pico Chemiluminescent substrate (Thermo Scientific) and devel-
oped on photographic film. Uncropped blots can be found in the source data file.
RT-PCR. Total RNA was extracted from mouse tissues using Trizol reagent
(Invitrogen) as per manufacturer’s instructions, resuspended in water, and quan-
tified with a Nanodrop 1000 spectrophotometer (Thermo Scientific). SuperScript
III reverse transcriptase (Invitrogen) was used to produce cDNA from 1 μg of RNA
and subsequent amplification was obtained with the KOD hot start DNA poly-
merase (Novagen). A list of all primers is provided in Supplementary Table 1. PCR
products were resolved on a 1.5% agarose gel and imaged with an Azure c-600 gel
documentation system.
cAMP ELISA. Adherent HEK293-T cells were transiently transfected with either a
plasmid encoding mouse Adgrd1, or a negative control encoding membrane-tethered
EGFP (vector), or were treated with the transfection reagent Lipofectamine 2000 alone
(mock). Twenty-four hours after transfection, cells were seeded on a streptavidin-
coated microtitre plate that had been pre-incubated with the mouse PLXDC2 or
control rat Cd200 biotinylated ectodomains. After three hours at 37 °C, the levels of
cyclic AMP were determined in duplicate using a cAMP ELISA kit (ADI-900-066,
Enzo Life Science) according to the manufacturer’s protocol, and normalised to the
total protein concentration determined using the Bradford assay (ThermoFisher
Scientific). One-way ANOVA showed a significant variation among conditions
(F5,12= 43, p < 0.0001) and a post-hoc Bonferroni test indicated that intracellular
cAMP differed significantly in Adgrd1-transfected cells treated with Plxdc2 compared
to Adgrd1-transfected cells treated with the control protein CD200 (p= 0.0391).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data supporting the findings of this manuscript are available in the Source Data file and
from the corresponding author upon reasonable request. Source data are provided with
this paper.
Received: 6 December 2019; Accepted: 29 January 2021;
References
1. Corpa, J. M. Ectopic pregnancy in animals and humans. Reproduction 131,
631–640 (2006).
2. Shaw, J. L. V., Dey, S. K., Critchley, H. O. D. & Horne, A. W. Current
knowledge of the aetiology of human tubal ectopic pregnancy. Hum. Reprod.
Update 16, 432–444 (2010).
3. Croxatto, H. B. & Ortiz, M. E. Egg transport in the fallopian tube. Gynecol.
Invest. 6, 215–225 (1975).
4. Knobil, E. et al. The physiology of reproduction, second edition.
Endocrinologist 5, 77–78 (1995).
5. Pauerstein, C. J. & Eddy, C. A. The role of the oviduct in reproduction; our
knowledge and our ignorance. J. Reprod. Fertil. 55, 223–229 (1979).
6. Humphrey, K. W. Observations on transport of ova in the oviduct of the
mouse. J. Endocrinol. 40, 267–273 (1968).
7. Greenwald, G. S. A study of the transport of ova through the rabbit oviduct.
Fertil. Steril. 12, 80–95 (1961).
8. Coy, P., García-Vázquez, F. A., Visconti, P. E. & Avilés, M. Roles of the
oviduct in mammalian fertilization. Reproduction 144, 649–660 (2012).
9. Weber, J. A., Woods, G. L. & Aguilar, J. J. Location of equine oviductal
embryos on Day 5 post ovulation and oviductal transport time of Day 5
embryos autotransferred to the contralateral oviduct. Theriogenology 46,
1477–1483 (1996).
10. Koester, H. Ovum Transport. in Mammalian Reproduction 189–228 (Springer
Berlin Heidelberg, 1970).
11. Bassilana, F., Nash, M. & Ludwig, M.-G. Adhesion G protein-coupled
receptors: opportunities for drug discovery. Nat. Rev. Drug Discov. 18,
869–884 (2019).
12. Leemans, J. C. et al. The epidermal growth factor-seven transmembrane (EGF-
TM7) receptor CD97 is required for neutrophil migration and host defense. J.
Immunol. 172, 1125–1131 (2004).
13. Yona, S. et al. Ligation of the adhesion-GPCR EMR2 regulates human
neutrophil function. FASEB J. 22, 741–751 (2008).
14. O’Sullivan, M. L. et al. FLRT proteins are endogenous latrophilin ligands and
regulate excitatory synapse development. Neuron 73, 903–910 (2012).
15. Cullen, M. et al. GPR124, an orphan G protein-coupled receptor, is required
for CNS-specific vascularization and establishment of the blood-brain barrier.
Proc. Natl Acad. Sci. USA 108, 5759–5764 (2011).
16. Lu, S. et al. Developmental vascular remodeling defects and postnatal kidney
failure in mice lacking Gpr116 (Adgrf5) and Eltd1 (Adgrl4). PLoS ONE 12,
e0183166 (2017).
17. Davies, B. et al. Targeted deletion of the epididymal receptor HE6 results in
fluid dysregulation and male infertility. Mol. Cell. Biol. 24, 8642–8648 (2004).
18. Chen, G., Yang, L., Begum, S. & Xu, L. GPR56 is essential for testis
development and male fertility in mice. Dev. Dyn. 239, 3358–3367 (2010).
19. Liebscher, I. et al. A tethered agonist within the ectodomain activates the
adhesion G protein-coupled receptors GPR126 and GPR133. Cell Rep. 10,
1021 (2015).
20. Stoveken, H. M., Hajduczok, A. G., Xu, L. & Tall, G. G. Adhesion G protein-
coupled receptors are activated by exposure of a cryptic tethered agonist. Proc.
Natl Acad. Sci. USA 112, 6194–6199 (2015).
21. White, J. K. et al. Genome-wide generation and systematic phenotyping of
knockout mice reveals new roles for many genes. Cell 154, 452–464 (2013).
22. Black, D. L. & Davis, J. A blocking mechanism in the cow oviduct. J. Reprod.
Fertil. 4, 21–26 (1962).
23. Gott, A. L., Gray, S. M., James, A. F. & Leese, H. J. The mechanism and control
of rabbit oviduct fluid formation. Biol. Reprod. 39, 758–763 (1988).
24. Belve, A. R. & McDonald, M. F. Directional flow of fallopian tube secretion in
the Romney ewe. J. Reprod. Fertil. 15, 357–364 (1968).
25. Kanayama, K. & Osada, H. Relationship between changes in volume of the
oviductal fluid in the ampulla and the descent of ovulated eggs from the
ampulla to the isthmus in mice. J. Int. Med. Res. 28, 20–23 (2000).
26. Black, D. L., Duby, R. T. & Riesen, J. Apparatus for the continuous collection
of sheep oviduct fluid. J. Reprod. Fertil. 6, 257–260 (1963).
27. Hino, T. & Yanagimachi, R. Active peristaltic movements and fluid
production of the mouse oviduct: their roles in fluid and sperm transport and
fertilization. Biol. Reprod. 101, 40–49 (2019).
28. Black, D. L. & Asdell, S. A. Transport through the rabbit oviduct. Am. J.
Physiol. 192, 63–68 (1958).
29. Edgar, D. G. & Asdell, S. A. The valve-like action of the uterotubal function of
the ewe. J. Endocrinol. 21, 315–320 (1960).
30. Hamann, J. et al. International Union of Basic and Clinical Pharmacology.
XCIV. Adhesion G protein–coupled receptors. Pharmacol. Rev. 67, 338–367
(2015).
31. Araç, D. et al. A novel evolutionarily conserved domain of cell-adhesion
GPCRs mediates autoproteolysis: Cell-adhesion GPCRs mediates
autoproteolysis. EMBO J. 31, 1364–1378 (2012).
32. Coleman, J. L. J., Ngo, T. & Smith, N. J. The G protein-coupled receptor N-
terminus and receptor signalling: N-tering a new era. Cell. Signal. 33, 1–9
(2017).
33. Wright, G. J. Signal initiation in biological systems: the properties and
detection of transient extracellular protein interactions. Mol. Biosyst. 5,
1405–1412 (2009).
34. Martinez-Martin, N. et al. An unbiased screen for human cytomegalovirus
identifies neuropilin-2 as a central viral receptor. Cell 174, 1158–1171 (2018).
e19.
35. Bushell, K. M., Söllner, C., Schuster-Boeckler, B., Bateman, A. & Wright, G. J.
Large-scale screening for novel low-affinity extracellular protein interactions.
Genome Res. 18, 622–630 (2008).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21512-w ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:1251 | https://doi.org/10.1038/s41467-021-21512-w | www.nature.com/naturecommunications 11
36. Yulia, A., Singh, N., Lei, K., Sooranna, S. R. & Johnson, M. R. Cyclic AMP
effectors regulate myometrial oxytocin receptor expression. Endocrinology
157, 4411–4422 (2016).
37. Bohnekamp, J. & Schöneberg, T. Cell adhesion receptor GPR133 couples to Gs
protein. J. Biol. Chem. 286, 41912–41916 (2011).
38. Salih, S. M. & Taylor, H. S. HOXA10 gene expression in human fallopian tube
and ectopic pregnancy. Am. J. Obstet. Gynecol. 190, 1404–1406 (2004).
39. Ji, Y. F., Chen, L. Y., Xu, K. H., Yao, J. F. & Shi, Y. F. Locally elevated leukemia
inhibitory factor in the inflamed fallopian tube resembles that found in tubal
pregnancy. Fertil. Steril. 91, 2308–2314 (2009).
40. Savaris, R. F., da Silva, L. C., da Moraes, G. S. & Edelweiss, M. I. A. Expression
of MUC1 in tubal pregnancy. Fertil. Steril. 89, 1015–1017 (2008).
41. Wang, H. et al. Aberrant cannabinoid signaling impairs oviductal transport of
embryos. Nat. Med. 10, 1074–1080 (2004).
42. Tay, J. I. et al. Human tubal fluid: production, nutrient composition and
response to adrenergic agents. Hum. Reprod. 12, 2451–2456 (1997).
43. Dickens, C. J. & Leese, H. J. The regulation of rabbit oviduct fluid formation. J.
Reprod. Fertil. 100, 577–581 (1994).
44. Eddy, C. A., Antonini, R. Jr. & Pauerstein, C. J. Fertility following
microsurgical removal of the ampullary-isthmic junction in rabbits. Fertil.
Steril. 28, 1090–1093 (1977).
45. Miller-Delaney, S. F. C., Lieberam, I., Murphy, P. & Mitchell, K. J. Plxdc2 is a
mitogen for neural progenitors. PLoS ONE 6, e14565 (2011).
46. Tönjes, A. et al. Genetic variation in GPR133 is associated with height:
genome wide association study in the self-contained population of Sorbs.
Hum. Mol. Genet. 18, 4662–4668 (2009).
47. Kim, J.-J. et al. Exome sequencing and subsequent association studies identify
five amino acid-altering variants influencing human height. Hum. Genet. 131,
471–478 (2012).
48. Marroni, F. et al. A genome-wide association scan of RR and QT interval
duration in 3 European genetically isolated populations: the EUROSPAN
project. Circ. Cardiovasc. Genet. 2, 322–328 (2009).
49. Fischer, L., Wilde, C., Schöneberg, T. & Liebscher, I. Functional relevance of
naturally occurring mutations in adhesion G protein-coupled receptor
ADGRD1 (GPR133). BMC Genomics 17, 609 (2016).
50. Whittingham, D. G. Development of zygotes in cultured mouse oviducts.
I. The effect of varying oviductal conditions. J. Exp. Zool. 169, 391–397
(1968).
51. Skarnes, W. C. et al. A conditional knockout resource for the genome-wide
study of mouse gene function. Nature 474, 337–342 (2011).
52. Wright, G. J. & Bianchi, E. The challenges involved in elucidating the
molecular basis of sperm-egg recognition in mammals and approaches to
overcome them. Cell Tissue Res. 363, 227–235 (2016).
53. Green, M., Bass, S. & Spear, B. A device for the simple and rapid transcervical
transfer of mouse embryos eliminates the need for surgery and potential post-
operative complications. Biotechniques 47, 919–924 (2009).
54. Bartholdson, S. J. et al. Semaphorin-7A is an erythrocyte receptor for P.
falciparum merozoite-specific TRAP homolog, MTRAP. PLoS Pathog. 8,
e1003031 (2012).
55. Kerr, J. S. & Wright, G. J. Avidity-based extracellular interaction screening
(AVEXIS) for the scalable detection of low-affinity extracellular receptor-
ligand interactions. J. Vis. Exp. https://doi.org/10.3791/3881 (2012).
56. Chong, Z.-S., Ohnishi, S., Yusa, K. & Wright, G. J. Pooled extracellular
receptor-ligand interaction screening using CRISPR activation. Genome Biol.
19, 205 (2018).
57. Bianchi, E. & Wright, G. J. Cross-species fertilization: the hamster egg
receptor, Juno, binds the human sperm ligand, Izumo1. Philos. Trans. R. Soc.
Lond. B Biol. Sci. 370, 20140101 (2015).
Acknowledgements
We thank the Sanger Mouse Genetics Programme for generating the Adgrd1-/- mice and
for the initial phenotyping; the staff at the Sanger Research Support Facility for the
provision and help with the management of the mice; and Colin Barker from the Sanger
Workshop for the design and building of the surgery jacket. This work was funded by the
Medical Research Council (grant MR/M012468/1) and the Biotechnology and Biological
Sciences Research Council (grant BB/T006390/1) to EB and GJW and Wellcome Trust
(grant 206194) to GJW.
Author contributions
E.B. performed all experiments unless stated. Mouse surgery was performed by M.W.;
Receptor screening was performed by Y.S. and N.M.-M.; domain mapping experiments
were performed by A.A.-O.; electron scanning and transmission microscopy was per-
formed by DAG. The manuscript was written by E.B. and G.J.W.
Competing interests
N.M.-M. owns shares in the Genentech/Roche group. The remaining authors declare no
competing interests.
Additional information
Supplementary information The online version contains supplementary material
available at https://doi.org/10.1038/s41467-021-21512-w.
Correspondence and requests for materials should be addressed to G.J.W.
Peer review information Nature Communications thanks Masahito Ikawa, Tia Jackson-
Bey and the other, anonymous, reviewer(s) for their contribution to the peer review of
this work. Peer reviewer reports are available.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2021
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21512-w
12 NATURE COMMUNICATIONS |         (2021) 12:1251 | https://doi.org/10.1038/s41467-021-21512-w | www.nature.com/naturecommunications
